XML 31 R16.htm IDEA: XBRL DOCUMENT v3.22.2
Balance Sheet Components
 6 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components BALANCE SHEET COMPONENTS
Inventory
Inventory consisted of the following (in thousands):
June 30, 2022December 31, 2021
Finished goods$3,602 $3,911 
Work in progress3,944 2,828 
Raw materials11,315 10,447 
Total inventory$18,861 $17,186 
Accrued and Other Liabilities
Accrued and other liabilities consisted of the following (in thousands):
June 30, 2022December 31, 2021
Clinical studies$13,325 $10,653 
Professional fees8,257 5,780 
Deferred revenue4,295 4,208 
Short-term lease liability2,989 3,958 
Deferred payments for intangible assets2,906 2,000 
Contingent consideration2,778 2,114 
Capital expenditures2,537 2,612 
Laboratory processing fees & materials2,400 1,888 
Accrued royalty1,560 1,664 
Accrued shipping expenses704 670 
Other accrued expenses5,182 2,375 
Total accrued and other liabilities$46,933 $37,922 
CMS Accelerated and Advance Payment Program for Medicare ProvidersOn March 27, 2020, the U.S. government enacted the CARES Act. Pursuant to the CARES Act, CMS expanded its Accelerated and Advance Payment Program in order to increase cash flow to providers of services and suppliers impacted by the COVID-19 pandemic. CMS was authorized to provide accelerated or advance payments during the period of the public health emergency to any Medicare provider who submitted a request to the appropriate Medicare Administrative Contractor and met the required qualifications. During April 2020, the Company received an advance payment from CMS of approximately $20.5 million and recorded the payment as Deferred revenue - CMS advance payment on the Company's condensed consolidated balance sheet. During December 2020, the Company reassessed the Deferred revenue - CMS advance payment and repaid the entire amount in January 2021.